Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heparan Sulphate Glycosaminoglycan Chains Contribute to the Tethering of Coronal Factors and Are Important for Extracellular Vesicle-Mediated Fibroblast Activation.

Journal of extracellular biology·2026
Same author

Unravelling nanoscale chemistries in complex biological systems using photoinduced force microscopy (PiFM).

Faraday discussions·2026
Same author

Extracellular vesicle-mediated delivery of miR-181a-3p confers neuroprotection to degenerating retinal ganglion cells.

Experimental eye research·2026
Same author

Matrix-associated extracellular vesicles modulate human smooth muscle cell adhesion and directionality by presenting collagen VI.

eLife·2025
Same author

Antibiotic carry over is a confounding factor for cell-based antimicrobial research applications.

Scientific reports·2025
Same author

Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.

The Lancet. Oncology·2025

Related Experiment Video

Updated: Jul 5, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Human tumor-derived exosomes down-modulate NKG2D expression.

Aled Clayton1, J Paul Mitchell, Jacquelyn Court

  • 1Department of Oncology and Palliative Medicine, School of Medicine, Cardiff University, Velindre Cancer Centre, Whitchurch, Cardiff, United Kingdom. aled.clayton@velindre-tr.wales.nhs.uk

Journal of Immunology (Baltimore, Md. : 1950)
|May 21, 2008
PubMed
Summary
This summary is machine-generated.

Cancer exosomes expressing NKG2D ligands and TGF-beta1 down-regulate NKG2D on immune cells. This impairs lymphocyte recognition and killing, revealing a key cancer immune evasion strategy.

More Related Videos

Isolation and Characterization of RNA-Containing Exosomes
09:43

Isolation and Characterization of RNA-Containing Exosomes

Published on: January 9, 2012

Related Experiment Videos

Last Updated: Jul 5, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Isolation and Characterization of RNA-Containing Exosomes
09:43

Isolation and Characterization of RNA-Containing Exosomes

Published on: January 9, 2012

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Biology

Background:

  • NKG2D is a crucial activating receptor on immune cells like NK and T cells.
  • Cancer cells evade immune detection by reducing NKG2D expression.
  • Tumor-derived soluble factors, including TGF-beta1, contribute to NKG2D downregulation.

Purpose of the Study:

  • To investigate the role of cancer cell-derived exosomes in NKG2D downregulation.
  • To determine the impact of exosomes on NKG2D expression and function in CD8(+) T and NK cells.
  • To elucidate the mechanisms by which exosomes affect NKG2D signaling.

Main Methods:

  • Exosomes were produced by cancer cell lines and isolated from patient effusions.
  • NKG2D expression on NK and CD8(+) T cells was analyzed after exosome treatment.
  • The role of exosomal NKG2D ligands and TGF-beta1 was assessed using specific antibodies.

Main Results:

  • Cancer-derived exosomes significantly downregulated NKG2D on NK and CD8(+) T cells.
  • TGF-beta1 on exosomes was identified as the primary driver of NKG2D downregulation.
  • Exosome-treated lymphocytes showed impaired NKG2D-dependent functions, including IFN-gamma production and cytotoxicity.

Conclusions:

  • Exosomes are key mediators of cancer immune evasion by downregulating NKG2D.
  • Targeting exosomal TGF-beta1 may restore anti-tumor immunity.
  • NKG2D is a critical target for exosome-mediated immune suppression in cancer.